Colgate-Palmolive (NYSE:CL) Raised to Buy at StockNews.com

StockNews.com upgraded shares of Colgate-Palmolive (NYSE:CL - Free Report) from a hold rating to a buy rating in a report published on Tuesday.

Several other equities research analysts also recently weighed in on CL. Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a report on Monday, October 28th. JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a research note on Friday, October 11th. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and upped their price target for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. Stifel Nicolaus lowered Colgate-Palmolive from a "buy" rating to a "hold" rating and lowered their target price for the company from $105.00 to $101.00 in a report on Monday, October 28th. Finally, Piper Sandler assumed coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $105.11.

Colgate-Palmolive Stock Performance

Shares of CL stock traded up $0.48 during mid-day trading on Tuesday, hitting $92.39. 1,531,566 shares of the stock were exchanged, compared to its average volume of 4,403,277. The stock's fifty day simple moving average is $94.85 and its two-hundred day simple moving average is $98.67. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a 12-month low of $78.29 and a 12-month high of $109.30. The stock has a market capitalization of $75.48 billion, a price-to-earnings ratio of 26.47, a P/E/G ratio of 3.31 and a beta of 0.43.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.16%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.34% of the stock is currently owned by corporate insiders.

Institutional Trading of Colgate-Palmolive

Institutional investors and hedge funds have recently bought and sold shares of the company. Principal Financial Group Inc. grew its stake in Colgate-Palmolive by 4.9% during the 3rd quarter. Principal Financial Group Inc. now owns 997,147 shares of the company's stock worth $103,514,000 after buying an additional 46,944 shares during the last quarter. DGS Capital Management LLC increased its position in Colgate-Palmolive by 35.9% in the 3rd quarter. DGS Capital Management LLC now owns 8,625 shares of the company's stock valued at $895,000 after acquiring an additional 2,280 shares during the period. Garde Capital Inc. raised its stake in Colgate-Palmolive by 19.5% during the 3rd quarter. Garde Capital Inc. now owns 1,553 shares of the company's stock valued at $161,000 after acquiring an additional 253 shares in the last quarter. Peapack Gladstone Financial Corp boosted its position in Colgate-Palmolive by 2.4% during the 3rd quarter. Peapack Gladstone Financial Corp now owns 50,653 shares of the company's stock worth $5,258,000 after acquiring an additional 1,203 shares during the period. Finally, Tidal Investments LLC increased its holdings in shares of Colgate-Palmolive by 351.0% during the third quarter. Tidal Investments LLC now owns 284,568 shares of the company's stock valued at $29,541,000 after purchasing an additional 221,469 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.